an innovative clinical stage biotechnology company that is developing novel pain relief treatments for osteoarthritis

Hagay Drori

COO

 

Dr. Ygal Rotenstreich, MD

Co-Founder & Medical Director

 

Dr. Ifat Sher Ph.D,

Co-Founder & CSO

​

David Daily,

DALI Medical Devices:

Co-Founder & R&D Director​

Enhancing delivery of therapies to the back of

the eye

Everads-Therapy is developing a revolutionary drug and cell delivery system for delivering injectable therapies to the back of the eye.
 
Posterior segment diseases of the eye are sight threatening and hard to treat due to their chronic and relapsing nature.

 

Everad`s delivery system, which delivers drugs to the back of the eye via the extravascular matrix of the choroid, will be superior to today’s intravitreal injections and other techniques.